
Lynn Lee
Research Assistant Professor-Affiliate · University of Cincinnati Medical Center Inc.
Credentials: · ·
History
Research
JCI Insight · 2017 · First of 15 authors · 82 citations
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
Cancer Discovery · 2022 · 73 citations
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
Nature Communications · 2020 · Last of 12 authors · Corresponding · 60 citations

4 papers

3 papers

3 papers

3 papers

3 papers

3 papers

3 papers

3 papers
Grants
- 2021–2027
Targeting MBNL1-Mediated Alternative Splicing in MLL-Fusion Leukemia
National Cancer Institute · K08
Contact PI · $980.6K · Cincinnati Childrens Hosp Med Ctr
Clinical trials
- 2025–2028
Sub-investigator · Recruiting · Phase 2
Healx Limited



